Why the study?
Does growth hormone replacement therapy improve outcomes in patients with adult-onset growth hormone deficiency?
Does growth hormone replacement therapy improve outcomes in patients with adult-onset growth hormone deficiency?
Answers are grounded in this paper and cite their sources.
Growth hormone replacement in adult-onset deficiency improves quality of life and body composition, but long-term benefits remain unclear.
Growth hormone (GH) deficiency is a condition recognized to occur in individuals who have had multiple pituitary hormone deficiencies as a result of pathological processes or neurosurgical interventions. The indications, benefits, and risks of GH replacement therapy will be reviewed with an emphasis on those patients who were adults with the deficiency first emerged. The results of this analysis indicate that, although a measurable improvement can be detected in the patient's quality of life, body composition, and some cardiovascular parameters, the larger questions of long-term benefit and patient selection currently remain unanswered.
No takes yet. Share an insight, caveat, or question.
Monique Piersanti (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: